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Education and debate
Ethical debate
Too drunk to care?
What should doctors do if they are faced with a medical emergency after they have had a few alcoholic
drinks? Dr David Cressey describes how, although not entirely sober, he felt compelled to help an
unconscious person at a sports event, and two medical ethicists, a psychologist, and another doctor give
their views.
Ethanol, emergencies, and ethical dilemmas
David M Cressey
While attending a recent sports event as a spectator, I
was faced with a dilemma. I saw an incident in which a
spectator was left unconscious and could have injured
his neck. The injured man had been placed in the
recovery position but was not moving. As the official
crowd doctor was not immediately on hand, I felt I
should at least offer my services. However, I had had an
alcoholic drink. I told the attending ground steward
that I was an anaesthetist, and warned him of the risks
of a possible neck injury. The steward then asked for
my help. I quickly assessed the patient; he had a clear
airway, was breathing adequately, had a strong pulse,
was pink and well perfused. None the less he had a
coma score of 3, and I had seen him drinking and eat›
ing moments before the accident.
When the paramedics and official crowd doctor
arrived, the patient was fitted with a hard collar and was
placed on a scoop stretcher. Having introduced myself
to the crowd doctor and briefed him on the patient’s
state, I told him that I had had a drink. I then had to
decide whether I should participate further in the
patient’s care. Here was a young man with a possible
neck injury and in a hard collar. He had a full stomach,
a coma score of 3, and although currently maintaining
his own airway, the protective reflexes were obtunded.
Immediate intubation had been considered but
deferred. If intubation became essential it could well
have proved technically demanding. While acknowl›
edging the quality of training and skills in airway man›
agement of paramedical and medical staff from other
specialties, my contribution as an experienced anaes›
thetic specialist registrar with daily practice of
intubation could have proved crucial here. I therefore
chose to accompany the patient and the crowd doctor
in the ambulance on the grounds that if the young man
failed to maintain his airway during transit I could
assist. In fact, the transfer was uneventful and the
patient was beginning to wake on arrival at the
hospital.
The problem
The question remains: at what level of intoxication do
doctors become too drunk to care for a patient? Under
their terms of service (paragraph 4), general practition›
ers are obliged to give treatment needed immediately
because of an emergency at any place in their practice
area when they are asked to do so. Caveats attached to
this include the fact that they must be available and be
physically capable of attending the emergency.
For doctors attending victims of mishaps that are
neither part of their professional remit nor part of
their terms of service, the case is rather different. There
does not seem to be any legal requirement for a doctor
to assist in an emergency where no duty of care or
professional relationship exist between the victim and
the doctor. However, the General Medical Council, in
its booklet Good Medical Practice, states that: “In an
emergency, you must offer anyone at risk the treatment
you could reasonably be expected to provide.” It seems
therefore that even if doctors have no legal obligation
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to assist in an emergency, they have an ethical one.
Indeed, does failure to help in an emergency leave the
doctor open to allegations of professional misconduct?
A matter of degree
In an emergency, when no alternative help is available,
it seems clear that aid should be given. When it
becomes a matter of the degree of experience of the
carer versus clarity of judgment, it is no longer black
and white. What effect does drinking alcohol have on
the “treatment you could reasonably be expected to
provide”? If you have taken any alcohol at all, should
you refrain from offering help if alternative trained
assistance is available, regardless of your relevant
specialist skills? When does it become more appropri›
ate for a less experienced but perhaps more mentally
alert carer to be responsible for a patient? What are the
legal implications if you assist and something goes
wrong? When are you too drunk to care?
Commentary: Guidelines could never be developed
Henk Rigter, Inez de Beaufort
Part of our work is to encourage doctors to reflect on
their actions and to adhere to morally appropriate
rules of conduct. However, not everything can or
should be codified. We expect off duty doctors to act as
good—or decent—Samaritans when they are con›
fronted with someone needing medical help. It would
be too much to expect them to be flawless in that
capacity or to programme their private actions so that
the benefit›risk ratio for those who might need their
services would always be optimal.
Dr Cressey’s dilemma is not as special as it seems on
first sight. True, alcohol may impair mental functions,
but it is not unique in that respect. Dr Cressey might just
as easily have been affected by a 20 hour shift at work or
a baby son who had kept him awake all night. The real
issue is that there is something special about alcohol.
Doctors may feel embarrassed for having drunk alcohol,
even if this was done in moderation and when off duty.
To act or not to act
Dr Cressey’s case was not extreme. There was a fellow
doctor on hand, who was made an accomplice—so to
speak—in the moral dilemma, and who took the
decision for Cressey to go ahead. Take a more
exceptional case. Imagine you are an obstetrician, the
only person on a plane with (para)medical training,
and you have been drinking champagne. A steward
calls for help as a woman is giving birth. She or her
child is sure to die if not given proper attention. Do you
offer your assistance? It is clear that you are qualified,
but the alcohol may have affected your competence.
On the other hand, a clumsy lay person might put
them in greater jeopardy. To act or not to act, that is the
question in medicine.
Make the decision even more difficult. It is not a life
or death situation as the woman may be able to hold on
until landing; or she is unconscious and not able to
give informed consent. You are an orthopaedic
surgeon and you smoked cannabis before boarding.
No guideline could deal with all these variations. You
must make up your own mind, however clouded it is.
Even if we wanted to draw up a guideline on alco›
hol use, it would be virtually impossible. Because of
individual differences in sensitivity, there is no clear cut
relation between the concentration of alcohol in the
blood and mental performance. Moreover, the
minimum concentration would have to be related to
the complexity of the medical skills required and also
to the risk and the severity of the possible
consequences of acting or not acting.
However, there is also a legal side—doctors may be
sued for making the wrong choices. We do not
welcome this development, which might prompt
doctors to save their own skin at the expense of people
needing treatment. We prefer to look at physicians as
good Samaritans rather than as liability risks.
A few rules of thumb may be offered to doctors. If
you have drunk alcohol, ask a sober qualified colleague
to treat the patient. If such a colleague is not at hand,
treat patients who would be at risk of dying if treatment
is withheld. Do not overestimate your skills—your judg›
ment may be impaired. Therefore, ask bystanders, if
present, for feedback on your behaviour.
Commentary: Balance the risk as best you can
Gareth Rees
You are at a dinner party. You are a pathologist who
last had skill training in resuscitation 30 years ago. A
businessman in his 60s develops chest pain and
collapses. He stops breathing and you are unable to
feel his pulse or hear a heartbeat. None of the other
guests knows what to do. Because you have had several
drinks you become concerned about the advisability of
further involvement and decide against trying external
cardiac massage and mouth to mouth ventilation.
Everyone else would feel that your decision was illogi›
cal and preposterous.
In other circumstances what is right may be much
less clear. There are no easy answers to Dr Cressey’s
questions. At a certain level of alcohol intake, a given
doctor’s performance will deteriorate to a point where
the risk›benefit ratio from a particular intervention in a
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particular emergency becomes unfavourable. Influenc›
ing factors include the amount of alcohol drunk, toler›
ance to it, the clinical problem, the nature of any
appropriate intervention, the doctor’s relevant exper›
tise, the availability and nature of alternative assistance,
and the risk attached to doing nothing. One potential
difficulty is that although doctors are theoretically best
placed to evaluate the various factors, their judgment
may be impaired.
No easy answers
Dr Cressey’s expertise could have been life saving. In
most situations where doctors are confronted with an
emergency outside hospital, whether or not they have
been drinking, appropriate and better care from para›
medical staff and other doctors is already present or
imminent. However, situations similar to that described
by Dr Cressey occur from time to time.
For most doctors a single drink is unlikely to impair
judgment and performance to an extent that would
justify withholding a clinically important intervention.
At this level of consumption most doctors are allowed
by law to drive at 70 miles per hour. While the poten›
tial for dilemma will usually arise at higher levels, many
patients have doubtless had cause to be grateful for the
ministrations of doctors who would have failed
breathalyser testing.
Act in good faith
Many hospital patients have doubtless had cause to be
grateful to junior doctors who have been busy on call
for such long periods that they would be unsafe to
drive. Doctors who have had more than one or two
drinks and find themselves unexpectedly in a “clinical”
situation must make every effort to recognise the
potential for misjudgment and to guard against
inappropriate enthusiasm for intervention. They
should evaluate the relative risks from intervention and
non›intervention. Occasionally, well meaning doctors
will get it wrong. However, it is rightly expected that
doctors should behave intelligently and responsibly
and act in good faith whenever there is such a call on
their services.
Commentary: Doctors can never have a moral holiday
Pat Walsh
From a moral point of view, Dr Cressey acted properly,
and probably wisely, in informing others that he had
been drinking. He thus shared responsibility with them
for any decision taken. Indeed, one might take this as
evidence that he was not, in that nicely ambiguous
phrase, “too drunk to care.” Several interesting moral
issues are raised by circumstances in which doctors
who are not entirely sober find themselves unexpect›
edly called on to act. But perhaps the question at the
heart of Dr Cressey’s unease is this one: could the
scope of the moral duty of care be such that no doctor
should ever be less than totally sober? Or, to put it
another way, are doctors ever morally off duty?
Ideal versus ordinary standards
Perhaps none of us is entitled to a moral holiday, in the
sense that we can ever justifiably claim there are
circumstances in which no moral demand can rightly
be made of us. In moral theory it is usual to distinguish
two levels of moral standards—the ordinary and the
ideal. Ordinary moral standards are the minimal
standards for moral decency that are required of
everyone. Ideal moral standards, however, may be
regarded as aspirational in character, and, because they
express the individual’s personal sense of obligation,
are not to be expected of everyone.
The person who acts in accordance with some ideal
typically acts in a way that goes beyond the demands of
duty. It is argued by some that these so called
supererogatory actions are wrongly conceived as such
because our best is what is morally required of us at
every moment. Nevertheless, most of us acknowledge
the possibility of heroic actions which, perhaps regret›
tably, are not to be expected of the majority.
No need for moral heroes
Dr Cressey’s worry, however, is not about whether doc›
tors must be moral heroes. He asks whether the
ordinary moral standards required of doctors preclude
social drinking. It does seem that some people have a
more demanding moral minimum than others, largely
because of a role they have voluntarily assumed.
Doctors, teachers, and parents are paradigm examples
of this. But while teachers are allowed to go off duty,
morally speaking, at the end of the working day,
parents and doctors cannot. However, even parents
can take time off as long as they have made adequate
provision for the care of their offspring.
It seems that doctors can never renounce their duty
to assist should the need arise, and therefore that they
are never morally off duty in this sense. On the other
hand, while we can ask of doctors what we ask of all
people in positions of responsibility for others—that
they are not drunk on the job—it is unfair to expect
doctors never to drink socially just in case a medical
emergency should arise. In fact, I do not think this is
required. If society were to demand that doctors hold
themselves in a constant state of preparedness to pro›
vide an optimal level of care, we would also require of
them the sort of lifestyle that would ensure peak physi›
cal and mental fitness. And, perhaps more tellingly, we
would not impose on them the sort of working hours
and conditions that lead to errors of judgment caused,
not by alcohol perhaps, but by exhaustion.
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Adjuvant tamoxifen: how long before we know how long?
Daniel Rea, Christopher Poole, Richard Gray
Despite recent advances, we still need more infor›
mation from large clinical trials to define the optimum
duration of tamoxifen treatment after surgery for
breast cancer. Tamoxifen is the most widely prescribed
and arguably the most important anticancer drug in
clinical use. It has been established beyond doubt that
adjuvant tamoxifen after primary treatment for early
breast cancer improves survival.1 2 Tamoxifen also
reduces the incidence of second primary breast
cancers,1 2 preserves bone mineral density,3 and may
lower the incidence of coronary heart disease.4
Although tamoxifen is generally well tolerated, it can
produce menopausal symptoms and, on occasion, it
has serious side effects, including an increased risk of
endometrial carcinoma.1 2 However, the benefits of a
few years of adjuvant tamoxifen treatment clearly out›
weigh the risks, and its widespread adoption is consid›
ered the major contributor to the recent fall in
mortality from breast cancer in the United Kingdom.5
Evidence on duration
For how long should adjuvant treatment with
tamoxifen be continued? Controversy remains. Recent
reports from randomised studies comparing different
treatment periods favour longer courses, but we are
still far from defining an optimum. We do know from
the preliminary findings of three European studies, in
which more than 10 000 patients participated, that
continuing treatment beyond two to three years
reduces the risk of cancer recurrence by about a
quarter.6–8 Longer follow up in these studies is required
to establish whether survival is also improved.
Treatment beyond five years has not been
adequately studied. None of the three studies (total 1700
patients) comparing adjuvant tamoxifen for five years
with longer treatment have found a noticeable
difference in survival—and they report conflicting results
on recurrence. The National Surgical Adjuvant Breast
Project (NSABP) B›14 study reported that survival free
of disease was worse in patients treated for 10 years than
in those treated for five years.9 A similar study from the
Eastern Cooperative Oncology Group reported an
opposite trend with fewer recurrences in those treated
for longer than five years.10 However, a Scottish trial
reported no appreciable differences in recurrence.11
Explaining inconsistency
These statistically inconsistent and puzzling results
may be explained partly by the early closure of the
NSABP study by its data monitoring committee. Based
on the study’s findings, a clinical announcement was
issued by the National Cancer Institute recommending
five years’ adjuvant treatment as standard in breast
cancer that had not spread to the lymph nodes.12 This
recommendation, made before the European Coop›
erative Oncology Group’s data became available, has
been criticised as premature since it was based on a
comparatively small number of individual events.13
Although 1000 women participated in NSABP B›14,
only those with a good prognosis (no spread of cancer
to the lymph nodes) were included, so the total
number of adverse events was comparatively low.
There is further concern that follow up in all of
these trials is not yet sufficiently long for any potential
late benefits from prolonged tamoxifen treatment to
register. The worldwide overview of adjuvant
tamoxifen studies showed that benefit persisted for
several years after the tamoxifen treatment had been
stopped.2 Thus, delayed effects may have an important
bearing on the eventual interpretation of these trials.
Although further analysis of these trials is expected
early in the next millennium, it is unlikely that this will
produce definitive conclusions.
Need for reliable assessment
With an estimated one million women taking
tamoxifen as adjuvant treatment, even small benefits
would translate into many thousands of lives saved.
The risks and benefits must be defined as accurately
and as soon as possible. Even if new hormonal
approaches eventually supersede tamoxifen, a reliable
assessment of the optimal duration of tamoxifen treat›
ment is relevant. At present, all we can really say with
confidence is that two years’ adjuvant tamoxifen
treatment is less effective at preventing recurrence than
five years’ treatment. Further trials of tamoxifen
duration are therefore appropriate and necessary.
Major trials, definitive answers
Two major trials—aTTom (adjuvant tamoxifen treat›
ment offers more?) in the United Kingdom and
ATLAS (adjuvant tamoxifen longer against shorter)
Summary points
Tamoxifen is the most widely prescribed
anticancer angent; used as adjuvant therapy it is a
major contributor to the recent decline in breast
cancer mortality
Controversy remains over how long tamoxifen
treatment should be continued
Continuing treatment beyond two to three years
reduces the risk of recurrence, which may result
in improved survival
Treatment beyond five years has not been
adequately studied; there are conflicting results
from three small studies
Large scale recruitment into ongoing studies is
needed to resolve the uncertainty over the
balance of benefits and risks of long term
adjuvant tamoxifen
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internationally—are currently aiming to recruit at least
20 000 women in order to answer definitively the ques›
tion on duration of adjuvant tamoxifen. These parallel
trials are designed pragmatically with randomisation at
the point when “substantial uncertainty” arises as to
whether to stop or continue tamoxifen treatment. At
this point women who give informed consent are ran›
domised to stop or continue adjuvant tamoxifen for at
leastfivemoreyears.Thetrialsarethereforeabletoaccom›
modate divergent and evolving clinical opinion. Indeed
recruitment into these trials has shown that the point at
which doctors become uncertain about continuing
treatment has shifted appreciably—from around two
years towards five years—undoubtedly in response to
publication of the recent European studies (figure).
Trial entry
All doctors treating breast cancer patients should be
aware of the uncertainty over how long adjuvant
tamoxifen should be prescribed for. This now includes
general practitioners since patients are often still taking
tamoxifen when they are discharged from hospital
follow up. When in doubt about stopping treatment,
entry into a tamoxifen duration trial through a
participating local breast unit should be considered.
Only through widespread support for these studies can
we resolve the complex balance of benefits and risks of
long term adjuvant tamoxifen treatment.
Information about aTTom and ATLAS is obtainable from the
aTTom Study Office, CRC Trials Unit, The Medical School, Bir›
mingham, B15 2TA or ATLAS Study Office, CTSU, Radcliffe
Infirmary, Oxford, OX2 6HE.
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As well as giving our usual audit data on decision and
publication times, we provide here data on the BMJ ’s impact
factor since 1990, accesses to our web site (www.bmj.com),
and data on submissions and acceptances for both articles
and letters, over the past five years.
Time to decision and publication
We aim to make a decision on publication within eight
weeks (56 days); to reject papers unsuitable for external peer
review within two weeks (14 days); and to publish a paper
within eight weeks of acceptance. The table below gives data
on our performance in the second half of last year, together
with previous years’ performance since we started recording
it in 1993.
Overall our performance on decision times improved in
the second half of last year, while that on publication times
deteriorated—largely owing to our having accepted more
articles than usual in nearly all sections. Between July and
December we made a decision within 56 days for 85% of all
papers submitted (1762/20 260) and for 59% of those
accepted (103/174). We accepted 70% within 66 days, and the
mean time to accept a paper was 54 days. We met our target
of rejecting papers without peer review within 14 days for
61% of papers (846/1396); 86% were rejected within 24 days.
Overall we published only 19% within eight weeks of
acceptance, 24% within 10 weeks, and 32% within 12 weeks.
Of full research papers, however, we published 24% within
eight weeks, 30% within 10 weeks, and 44% within 12 weeks.
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Table 1 BMJ impact factor 1990›7
Year 1990 1991 1992 1993 1994 1995 1996 1997
Impact factor 3.29 3.76 3.87 4.34 4.50 4.41 4.55 4.95
Table 2 Web accesses to www.bmj.com: number of separate
hosts served
1996 (21›27 Dec) 1997 (21›27 Dec) 1998 (17›23 Apr)*
Hosts served 5762 10 608 20 015
*After relaunch of BMJ site with full text.
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One hundred years ago
The depopulation of France
The late Professor Tarnier, according to Dr Dureau, was the first
private person who offered a reward to increasers of the
population. He instituted a prize of 100 francs for each child that
might be born in the year after its institution, namely, 1892, in his
native village, Arc›sur›Tille, Burgundy. Dr CabanŁs, however, has
found that a similar prize had already been offered for the same
year by the Comte de Chardonnet, Mayor of Charette. It appears
that not a single child was born in the village of Charette in 1891.
The noble Mayor announced by beat of the drum in the market
place that “We, Mayor of Charette, promise to award a prize of
one hundred francs to every woman who brings a viable child
into the world in the course of the year 1892. The said reward will
be delivered at the end of the week following the declaration of
the birth of the child at the Town Clerk’s office. The parents must
be inhabitants of the commune of at least one year’s standing and
the child must be born in wedlock.” Nobody can deny the
advisability of these qualifications, but it seems strange that the
necessity for increase of population is so keenly felt in France that
a mayor should think it right to deliver such a proclamation.
(BMJ 1898;i:170)
Table 3 Number of submissions of articles to BMJ 1993›7 and acceptance rates from different parts of the world 1993›7
1993 1994 1995 1996 1997
No submitted % Accepted No submitted % Accepted No submitted % Accepted No submitted % Accepted No submitted
Total 4690 18 4495 16 4572 17 4637 18 4732
Europe:
UK 3454 20 3225 18 3153 19 3130 20 3065
Non›UK 702 12 727 9 839 12 881 13 1015
North America 134 19 153 19 186 22 186 20 242
South and Central America 9 44 10 0 13 31 12 8 18
Australasia 182 18 145 17 147 18 147 19 150
Africa 39 13 37 16 29 24 41 24 52
Middle East 68 12 66 5 64 12 63 10 61
Asia 102 13 132 5 141 7 177 5 129
Table 4 Number of letters submitted to BMJ and proportion accepted by region, 1993›7
Region
1993 1994 1995 1996 1997
No submitted % Accepted No submitted % Accepted No submitted % Accepted No submitted % Accepted No submitted % Accepted
United Kingdom 3448 46 3227 45 3698 38 3306 39 3146 36
Rest of Europe 236 43 261 46 214 36 191 34 251 33
North America 121 40 123 46 112 41 103 47 125 31
Africa 33 27 27 30 15 47 23 22 34 35
Middle East 22 27 28 36 31 16 16 19 24 8
Asia 64 23 42 26 70 20 61 30 74 26
Australasia 95 28 97 49 78 40 66 41 76 42
Central and South America 8 25 12 17 10 0 4 0 11 55
Total 4027 45 3817 45 4230 38 3770 38 3741 35
Table 5 Results of BMJ audits. Values are percentages unless stated otherwise
Audit
Decision within 56 days Accepted papers Rejected papers (no peer review) Publication after acceptance within:
All
papers
Accepted
papers
Decision within
66 days
Mean time to
decision (days)
Decision within
24 days
Mean time to
decision (days)
8
weeks
10
weeks
12
weeks
1993:
Jan›June 88 73 85 41 76 19 38 75 95
July›Dec 86 62 75 50 84 18 27 66 85
1994:
Jan›June 88 64 76 48 84 18 13 24 57
July›Dec 83 64 73 51 73 21 40 67 87
1995:
Jan›June 72 41 53 69 56 26 38 60 76
July›Dec 73 34 43 81 65 22 32 50 73
1996:
Jan›June 81 43 59 59 65 24 19 35 53
July›Dec 76 53 56 88 62 23 29 52 66
1997:
Jan›June 68 35 45 81 72 20 24 42 61
July›Dec 85 59 70 54 86 15 19 24 32
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Coping with loss
Facing loss
Colin Murray Parkes
To conclude this series, I examine some of the
problems that explain why the care that is needed in
situations of bereavement and loss may not be
provided, and I suggest some solutions.
Why losses may go unrecognised
Although the death of a spouse or child is a public
event that seldom goes unrecognised, many other
types of loss do not attract attention or support to
those who suffer them. This has been called disenfran›
chised grief.1 It is not unusual for more than one of the
reasons listed in the box to apply.
People with unrecognised losses are of particular
importance to members of the healthcare professions
for three reasons: their physical and mental health may
be at risk; they seldom come to the notice of the usual
caring agencies; and we often find out about them
because of our access to confidential information that
is hidden from others. In fact we may be the only
people who are in a position to help.
Hidden losses
Hidden losses arise when a relationship has been kept
secret, when the ending of the relationship cannot be
acknowledged, or when the loss is associated with feel›
ings of shame or inadequacy. If the bereaved person
has had a homosexual relationship that has been con›
cealed, the death of the partner may be a great cause
for grief that the survivor may not feel free to express
or share. Often the relationship has been known or
guessed at by others who colluded by pretending that
the relationship did not exist. The loss is not admitted
to by anyone: the bereaved try hard to hide any expres›
sion of grief for fear that their secret will be discovered,
and others are debarred from expressing sympathy or
support.
There is a lot of truth in the saying “To understand
is to forgive,” and this applies to the patient as well as
the doctor. People with secrets are often trying to hide
from themselves—“If I don’t tell anyone about it I won’t
have to think about it and can pretend that it is not
true.” Like most forms of denial this device is seldom
successful because we have to be on our guard against
the danger that we are trying to avoid. Once the secret
has been shared we no longer need to be on our guard
against it.
Trust has to be earned: we have no right to expect
our patients to trust us and often have to address this
problem before attempting to deal more directly with
the secrets. By reassuring patients that anything they
tell us will be treated as confidential and putting our
case notes aside when confidential issues are touched
on, we show sensitivity and earn trust. In the end, how›
ever, it is likely to be non›verbal messages—the
welcoming smile, a hand on the shoulder at the right
moment, a flash of eye contact when some particularly
dangerous topic has been touched on—that indicate
our trustworthiness.
Problems of this kind are particularly common
among people with HIV infection and other diseases
that may be sexually transmitted. They are also
common consequences of mental illnesses, which may
be aggravated as a result of these problems.
Members of the healthcare team often have
confidential information that may make us the only
people who can give support to patients with such dis›
eases. Some patients will shut themselves up at home,AD
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Summary points
Losses may go unrecognised because they are
concealed or avoided by those who experience
them, misrepresented by caregivers, or take place
very gradually
Losses are often concealed or misrepresented out
of kindness, but the supposed harmful
consequences of revealing the truth rarely match
the harmful consequences of concealment
Men, military personnel, members of emergency
services, and doctors are often expected to inhibit
grief. They are also likely to find it difficult to ask
for help
Even mothers who have planned for and eagerly
anticipated the birth of a child may need to grieve
for the many losses that result from it
The most important thing that members of the
healthcare team have to offer to those who are
afraid is a relationship of trust and respect, from
which they can explore the situation they face,
share the feelings that arise, and review the
implications of loss
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refuse necessary treatments, and resist attempts at
rehabilitation. By criticising or browbeating them we
only increase their feelings of insecurity and fear. By
treating them with respect, withholding judgment, and
encouraging them to believe in themselves, we stand a
much better chance of helping.
Concealment or misrepresentation of
losses by caregivers
Losses are often concealed or misrepresented out of
kindness. A mother may not tell her young son that his
father is dying because she wants to protect him from
the pain that he will experience if he learns the truth. A
nurse in a residential home for the elderly may not
invite residents to attend the funeral of another
resident because she thinks it will upset them. A doctor
may give quite unjustified reassurance to a patient with
heart disease for fear that the truth will cause the
patient to drop dead.
In an important recent study, 50 people with learn›
ing disorders who were being cared for in the commu›
nity and who had recently lost a parent were compared
with 50 others who had not been bereaved.2 Those who
had been bereaved were unlikely to have been warned
of the coming death of their parent and to have been
taken to visit the grave, and only half were known to
have attended the funeral. They had much higher
scores on measures of anxiety, depression, hyperactiv›
ity, stereotyped movements, and other indicators of
distress. Despite this, most of the professional and fam›
ily carers who looked after them were quite unaware of
their distress and inclined to attribute their symptoms
to brain damage rather than to bereavement and its
secondary consequences.
Concealment of a loss often leads to bad
consequences: the loss may eventually become obvious
and the deception may be seen through; inaccurate
information may leave the recipient ill prepared to deal
with subsequent events; and an opportunity to help
someone to cope with reality may have been missed.
The supposed harmful consequences of revealing the
truth rarely match the harmful consequences of
concealment.
Gradual losses
When a loss is very gradual or imperceptible, or the
person has been born with a disfigurement or disabil›
ity of which they only gradually become aware, they
often succeed in ignoring or minimising the implica›
tions of the loss. So too do their family, friends, and
caregivers, who may not understand that depression or
other psychological symptoms are often indications
that the person is becoming aware of the loss and that
the time has come for someone to acknowledge the
need to grieve and to support them through their
grief.
Why loss may go unrecognised
• Hidden losses associated with shame or stigma (for
example, HIV infection or mental illness)
• Concealment or misrepresentation of losses by
caregivers, as when caregivers conceal information
from children or elderly people
• Gradual losses, as when the imperceptible
progression of an illness is ignored (for example, in
infertility or Alzheimer’s disease)
• Avoided grief, as when people deny their need to
grieve for social or other reasons (for example, in
“macho” men after any loss or in mothers who have
mixed feelings on the birth of a baby)
Members of the healthcare professions may be the
only people in a position to help people with
unrecognised losses
Assumptions about loss and principles of care
Assumptions
Grief is an important experience that needs to be
acknowledged
Losses that have been anticipated and prepared for are
much less likely to give rise to later psychiatric and other
problems than losses that are unexpected
Many of the losses that are met with in medicine affect
the lives of members of the families of our patients
Grieving people tend to oscillate between avoiding and
confronting grief; problems arise when either of these
ways of coping predominates
Anger and shame can complicate the course of grief
The minority who are at special risk (people with
traumatic losses, personal vulnerability and lack of social
support) can be identified before or at the time of a loss
Losses can affect the carer as well as the cared for;
doctors are not immune to grief
Principles
Members of the caring professions have many
opportunities to do this
By sensitively imparting information and support we can
help people to prepare for the losses that are to come
It is the family, which includes the patient, that is the unit
of care
Some people need permission and encouragement to
grieve and reassurance of the normality of grieving
People may also need permission and reassurance that
they do not have to grieve all of the time; they may need
opportunities and encouragement to re›plan their lives
in a way that values the past
We need to reserve judgment and show understanding
Members of the caring professions are well placed to
assess risk, to give support, and advise those who need
additional help how to get it
We need to become aware of our own reactions to our
patients and their illnesses, and to acknowledge and seek
to meet our needs for support
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Infertility
The infertile couple often deny for many years that
they will never succeed in conceiving. As Bryan and
Higgins put it, “Some secretly carry on hoping against
all odds, if only to postpone the inevitable pain and
misery of giving up hope.”3 They may not realise that
their increasing irritability, their resentment of people
who have had an abortion, and their loss of sexual
libido are all symptoms of grief. When, eventually, they
do acknowledge the true situation, each partner will
grieve in an individual way and this may make it hard
for them to support each other. Each may blame the
other, for infertility is always assumed to be somebody’s
“fault.” Not only is infertility inconspicuous, it is also
something about which people often feel ashamed.
Infertile couples often keep their sadness to themselves
and social support from friends and family is lacking.
Those unable to conceive may feel jealous of those
who can and friends with children may not like to draw
attention to their good fortune by sympathising.
Alzheimer’s disease
Wives and husbands of people with Alzheimer’s
disease may be reluctant to acknowledge that they no
longer recognise the person they married. Both social
pressures from their families and allegiance to the
spouse force them to pretend that the gross change in
personality that has resulted from the disease has not
impaired their relationship. Sadly, the failure to
acknowledge the truth may cause them to blame the
spouse for failing to be the sensitive, intelligent person
he or she always was. Support and understanding may
be needed if the wife or husband is to grieve for this
very real loss and find a way of living with and support›
ing the different spouse whom they now have. When
eventually the spouse dies, relief may make it hard to
grieve at a time when everyone seems to expect it.
In these cases the understanding and support of
members of the healthcare team can facilitate grieving,
mitigate the feelings of anger and guilt that are inevita›
bly present, and point the person towards the help of
others who have experienced similar difficulties—
through, for example, Issue (formerly the National
Association for the Childless) and the Alzheimer’s Dis›
ease Society.
Avoidance of grief
Although most people oscillate between confronting
and avoiding grief, extreme avoidance of grief always
takes place for a reason. People may avoid grief
because they are members of a family or a society in
which grief is frowned on; they may avoid it because
they fear the consequences if they should express it; or
they may simply believe that they have more important
things to do.
Cultural influences may determine when and how
grief is expressed, and anthropologists have reported
great variation from one society to another.4 Whether
or not the societal inhibition of grief within a culture is
harmful is a matter for debate and research. One thing
seems clear, however.
Even within cultures there is great variation. Men,
in particular, are often expected to inhibit their grief.
This may explain the finding that, whereas women
usually show more overt distress in the first year of
bereavement than men and are more likely to seek
psychiatric help, men take longer to return to the levels
of adjustment of married controls than women.5 They
are also more likely to die from heart disease after
bereavement than are women of the same age.6 It
seems that it is the inhibition of grief that is damaging
to the heart rather than its expression. Bereaved men
benefit more than women from therapies that encour›
age them to express feelings; bereaved women are
more likely to benefit from help in reviewing and
reshaping their assumptions about the world.7
Cultural pressures also prescribe when and
whether grief is an appropriate response. Mothers who
have babies are under considerable social pressure to
rejoice rather than grieve. For many mothers to be,
however, pregnancy is unwanted, and even those who
have planned for and eagerly anticipated this event
may need to grieve for the many losses that result from
it. Kumar and Robson found that 10% of mothers had
clinical levels of depression during pregnancy and 14%
in the first three months thereafter.8 Similar figures
have been reported in five other studies reviewed by
Brockington.9
A mother may experience considerable shame if,
because of feelings of depression, fear, or grief, she is
lacking in maternal feelings for her new baby. She is
likely to be acutely conscious of the danger that her
lack of feeling constitutes to her child. If she finds the
courage to admit this, we need to recognise the
seriousness of the situation and to reassure her that it is
not her fault. If we help her through the period of
emotional turmoil, maternal feelings will usually
emerge. If they do not the mother will need and should
benefit from the help of a child psychologist.
Another group who tend to deny their own needs
to grieve are members of the caring professions,
particularly doctors, who spend their lives caring for
others but who often find it difficult to acknowledge
their own emotional needs. If we accept that it is
appropriate and therapeutic for our patients and their
The supposed harmful consequences of revealing the
truth rarely match the harmful consequences of
concealment
Each partner in an infertile couple will grieve in an
individual way, and this may make it hard for them to
support each other
The wife or husband of someone with Alzheimer’s
disease may need support and understanding if they
are to grieve for the loss of the person they married
Those who overreact to loss will benefit from
opportunities to re›examine their negative
assumptions about themselves and their world
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families to express grief, why should we deny ourselves
that privilege? It would seem that, like soldiers and
members of the emergency services, we are trained to
remain calm in the face of danger. This leads us to the
assumption that, even when the emergency is over, we
have no need to get upset. Yet, as Bennet’s paper in this
series showed, such stoicism is bought at a cost and
doctors who find ways to meet their own needs for
emotional expression and support are likely become
better doctors and to find greater satisfaction in their
work.10
Chronic grief
Some people become stuck in states of chronic grief that
cannot easily be put aside; this may result from high lev›
els of anxiety about the world that now exists. Grief is
both an expression of distress and a cry for help.
A woman who has had a bad experience of
pregnancy may experience high levels of anxiety and a
propensity to depression which may spoil her next
pregnancy. Similarly people who have recovered from
mental illness may dread its return. If they experience
a loss that triggers natural feelings of grief they may
convince themselves that they are “breaking down,”
and this may indeed increase the risk that they will.
Those who overreact to loss will benefit from
opportunities to re›examine their negative assump›
tions about themselves and their world, to review and
replan their lives in ways that value and build on the past,
and to venture forth into a world that seems more dan›
gerous than it really is. Nothing succeeds like success,
and quite small beginnings can lead to a restoration of
confidence that eventually allows great progress to be
achieved. There is much to be said for John Bowlby’s
claim that the most important thing that we have to offer
frightened or grieving people is a “secure base,” a
relationship of respect—with a person who has the time,
knowledge, and willingness to remain involved—that will
last them through the bad times.11
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Health needs assessment
Assessment in primary care: practical issues and possible
approaches
John R Wilkinson, Scott A Murray
This article is a practical guide to help primary care
groups (as set out in the NHS white papers1 2) and also
individual practice teams assess the health needs of their
respective populations before providing or commission›
ing services to meet these needs. Historically, much serv›
ice provision has been service led rather than needs led,
provided as before and at the convenience of providers
rather than patients. The needs of patients are now
accepted as being central to the NHS. An explicit frame›
work is needed to help assess needs more systematically,
to demystify the process, and to help prioritise and
action changes.3 This paper outlines an approach that is
feasible for individual practices, groups of practices, and
populations of around 100 000 people (typically the size
of the new primary care groups described in the white
paper).
Do we get involved with wider health
needs or just health service needs?
Health professionals understandably tend to think of
health needs in terms of services they can provide.
Patients may have different ideas about what affects
The articles in this
series are adapted
from Coping with
Loss, edited by
Colin Murray
Parkes and
Andrew Markus,
which will be
published in July.
Summary points
A practical strategy for assessing local health
needs is required
This approach uses practice held data, routinely
available local statistics, a patient/public
consultation exercise, and (possibly) a postal
survey to gain various perspectives on need
Unless specific, useful summary data are obtained,
details will obscure the larger picture
Stages in this strategy are to collate the
information, assess priorities, and plan and
evaluate changes
Time and resources must be available at
practice and locality level, but many important
health needs cannot be met by health services
alone
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their health. This might include getting a job, having a
roof over their head, or having a bus route which
makes getting to see the doctor easy. A group of prac›
tices may decide that they do not have the time and
resources to consider these types of needs, and they
may feel even less confident about being able to do
anything about such needs. But if primary care has the
aim of improving the health status of individuals as
well as providing health services, such factors must at
least be identified for action by someone else. Lalonde,
when minister of health in Canada, emphasised the
importance of lifestyles and the environment on health
as well as the influences of human biology and health›
care provision.4 Thus this paper embraces needs for
health—needs for services and more general needs.
Levels, approaches, and methods
The process of health needs assessment can be carried
out at different levels, from international down to indi›
vidual patient. Different approaches can be used at
each level (from global to specific diseases).
Levels
Needs assessment can be carried out at various levels:
x International—By the World Health Organisation,
for example
x National—The advantage of tackling some national
priorities locally (such as mental health) is that it may
be easier for health authorities or boards to fund iden›
tified gaps in services. But remember that the most
common complaints presented by patients—stress,
arthritis, and dyspepsia—have never been identified as
national priorities5
x Regional—the need for a liver transplantation service
could be assessed at this level
x Health authority or board level—The needs for neona›
tal care, obstetric care, or dietetics may be assessed at
this level
x Locality—The creation of primary care groups will
lead to increasing importance for needs assessment to
be undertaken at this level. Generally, larger popula›
tions will produce more robust results than single
practices. There is also no need for every practice to
carry out similar studies when it is unlikely that there
will be different needs between practices. Issues
suitable for tackling at this level might include
unwanted pregnancy, dental caries, inequalities in
service provision of community nursing
x Practice specific—It is worth thinking about a single
piece of needs assessment work where a practice is
relatively large and is situated in an area of particular
need. Issues such as mental health and drug addiction
may be particularly relevant
x Small neighbourhood—Some practices have a group
of patients who live in a well defined disadvantaged
area. Such an area can usefully be targeted
x Individual—used daily in consultations by general
practitioners and nurses.
Approaches
When using a global approach, get an initial overview
of the health and social needs of the population group,
then identify which of a variety of interventions might
best improve the health and wellbeing of patients.
Issues relating to the wider determinants of health can
be taken to the relevant agencies for action (in London
and in Edinburgh, bus routes have been changed and
play areas developed).
A focused approach can centre on:
x A specialty (mental health, for example)
x A disease (epilepsy, Alzheimer’s disease, cerebral
palsy, or diabetes6)
x A client group (elderly people, single mothers, the
unemployed, farmers)
x Groups waiting for interventions (people awaiting
an operation or physiotherapy)
x Vulnerable groups of patients (ethnic minorities, etc)
x Patients who are socially deprived, to address issues
of inequity.
Methods of assessing needs
Different information sources and methods of
investigating give complementary insights into health
needs generally.5 Practitioners should concentrate on
gathering the information that will give them the most
useful insights, rather than on collecting all sorts of
information that might turn out to be useful. A locally
appropriate mix of methods can use data from various
sources: information held by the practice, computer
records, and “soft” information from all members of
primary healthcare teams. These sorts of data are good
for assessing ongoing physical problems.
Local statistics are routinely available from health
authorities or health boards, hospitals, and the census.
Public consultation exercises, which can utilise focus
groups, rapid appraisal, or other methods of interact›
ing with local people, are good for uncovering
problems relating to drug abuse, HIV, and social issues.
A postal survey may be worth considering to
provide data about acute illness in the community and
suggestions for changes to services. A covering letter
by the patient’s general practitioner may improve the
return rate.
Detailed guidance on practical aspects is now avail›
able, including a workbook and a “really rough
guide.”7–11
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Involving others
Most approaches can be undertaken by an individual
or a group. Although group work is more difficult to
organise, there are major benefits. Group members
who work in the community, such as health visitors and
district nurses, have valuable knowledge of local needs
and will feel an ownership of the results if they have
been involved. Practice staff involved may require addi›
tional resources or locum cover. Public health and pri›
mary care can contribute complementary skills and
insights at every level.
Any practice or group of practices needs to decide
how the public will be involved at an early stage. Meth›
ods for involving the public have been described by
Mays et al.12
Consultants working in hospital or community
trusts usually have a clear picture of the needs for their
particular service. This can be a rich source of help,
advice, and information. Combining specialist exper›
tise and the experience of generalists can produce
valuable information. Other service providers should
also be considered, such as hospices and other
agencies both in the statutory and voluntary sector.
Depending on funding, some aspects of needs
assessment may be carried out by an external agency if
the relevant skills or time is not available (for example,
to carry out focus groups or a postal survey).
Defining the problem or area to be
assessed
Most practices and even locality groups will have little
time to devote to needs assessment, and therefore it is
important to target any effort in the most productive
way. A first needs assessment project needs to deliver
rapid success to stimulate those involved to progress
further. In a few practices—perhaps in an area of inner
city deprivation—the issues that need to be tackled will
be very obvious, but for most practices the priorities
will vary depending on the demographic profile, com›
mon illnesses, and social needs of the practice popula›
tion. Consider the frequency, impact, and costs of
different diseases. Priorities might be defined with the
following questions:
x Is there a realistic chance of achieving change?
x Is the cost of undertaking the work proportional to
the likely benefits?
x What are the priorities being suggested by other
agencies—the health authority or health board, social
services?
x Does the practice or primary care group wish to
look at issues that are not directly under their control
such as housing and transport?
Five stage approach
Stage 1: Collect routine practice information
Routine data from general practices can highlight needs
that are dealt with in primary care. The box lists data that
give an overall practice perspective on needs: ask your
practice manager to collect as much as is reasonably
available. Some computer software (such as GPASS in
Scotland) can generate a practice profile automatically.
This is especially useful for comparing practice data with
other practices, or for collating data for groups of prac›
tices. Several networks exist in different parts of the
country to optimise the use of such data.13
Stage 2: Collect hospital, community trust, and
census data
Standard “routine” hospital utilisation data does not
routinely get fed back to practices. Thus the knowledge
and understanding that most general practitioners
have of the hospital services that their group of
patients receive is limited. Although routinely collected
clinical data may contain inaccuracies,14 the quality of
some databases has substantially improved.15 With the
help of local public health departments, detailed
hospital utilisation can now be compared between
practices and localities. Such data must be interpreted
carefully, as demand and supply often have more influ›
ence on hospital usage than does need. Use of hospital
services may not be a proxy for morbidity in the com›
munity.16 The box on the next page lists the variables
which general practitioners working in Edinburgh’s
south east locality found most informative for
understanding the current usage of hospital services by
individual practices.
Health authorities and boards also have a range of
census information, available at small area level. This
Core practice data
• Age›sex profile in 5 year bands for male and female patients
• Prescribing details:
Repeat prescribing rates from practice computer
Collated prescribing figures (PACT or Scottish Prescribing Analysis)
• Prevalence of some specific chronic disease (for example, ischaemic heart
disease, chronic obstructive airways disease, asthma, epilepsy, psychosis,
thyroid disease, hypertension, diabetes)
• Data from practice’s payment details:
Percentage of patients attracting deprivation payments
Family planning uptake
Temporary residents
Obstetric care and other item of service payments
• Health promotion and disease prevention data:
Smoking, alcohol consumption, substance misuse, body mass index
Immunisation coverage (2 and 5 year olds)
Cervical cytology coverage
• Contacts with general practitioners:
Surgery consultation rate per 1000 registered patients per year
House call rate per 1000
Out of hours visits per 1000
• Knowledge (mostly implicit) of local health needs:
Health visitor: practice profile, breast feeding rates, use of other agencies
District nurse: workload details, observations in patients’ homes
Practice nurse: workload details (for example, influenza coverage rate)
Receptionists: patients’ perceptions, availability of appointments
• Deaths—causes, place of death, preventable factors
• Turnover of patients
• Other sources—suggestions box, patient participation group
• Notes search may yield:
Incidence of acute illnesses and symptoms presenting
Telephone ownership (percentage)
Unemployment rate, domestic problems documented
If reliable data (on use of investigations, referrals, etc) are available from
other sources, use these data rather than duplicate work in the practice for
the following:
• Use of investigations (per 1000 patients per year, individually for
microbiology, haematology, biochemistry, radiology, electrocardiography
• Referrals to physiotherapy, chiropody, occupational therapy (per 1000
patients per year)
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information is extremely useful to highlight social
inequities at small area level such as in an underprivi›
leged housing estate. Jarman and Townsend scores
may be available, but at practice or locality level the six
census categories listed in the box may be sufficient to
give a view of social need. Unless you request very spe›
cific, interesting summary data from the health author›
ity or board you will be swamped with too much detail,
which will obscure the larger picture and be too
lengthy for general practitioners to absorb.
At practice level such data can be presented at a
practice planning meeting and inform the practice’s
annual business plan. In southeast Edinburgh locality,
the above data were fed back at a meeting to which one
general practitioner from each practice was invited. Pro›
tected time—and hence a good attendance—was gained
making a fee from the general practice fundholding
management allowance available to all attendees. After
the abolition of fundholding, similar exercises should be
possible, using the management allowances associated
with the new primary care groups. This data highlighted
considerable variations in the use of inpatient services,
outpatient services, and community services such as
nursing and chiropody, with the two most common
reasons for admission (termination of pregnancy and
dental caries) both preventable. The general practition›
ers, after presentation of the data and discussion, left
written comments about what they found most interest›
ing about their practice, suggestions to improve or
extend the data, and how the data could be used by indi›
vidual practices and the locality. Subsequent meetings
are planned to gain other perspectives of need in the
locality from other data sources.
Stage 3: Gaining public involvement
Health professionals define “needs” in terms of
services that they can provide, whereas patients may
have a different perception of what would make them
healthier: a job, a bus route to the hospital, or some
advice on benefits, for example.Thus interaction and in›
put from patients and the public is vital to gain an “hon›
est consumer perspective.” It can be obtained through:
x Interviews with patients
x Informal discussions with, for example, voluntary
groups, community health council
x Suggestion boxes
x Complaints procedures
x Health forum
x Focus groups (with elderly or diabetic patients, for
example; see box)
x Rapid appraisal (see box, next page).
Stage 4: Undertake (or use an existing) postal survey
Surveys to assist local decision making must be
modestly defined and use a mixture of lay and medical
concepts. Computerised search and mail merge
facilities allow most practices to send questionnaires
(with covering letters and reply paid envelopes) to spe›
cific patient groups. A well conducted postal survey of
a representative sample can give a reliable estimate of
the true burden of morbidity in the population, and
may inform contract specification. Assistance will nor›
mally be required to select an instrument or to design
one, and with sampling and data analysis. Various vali›
dated instruments for generic and disease specific sur›
veys are available.20 Questions concerning the areas
outlined in the box on the next page may be especially
relevant, as such data may not be obtained easily from
other sources.
Hospital, community trust, and census data
Inpatient data
• Ten most frequent diagnoses made at hospital inpatient discharge (rates
per 1000 registered patients), tabulated in descending order. (ICD›10 codes
to three digits are recommended; transfers are excluded; patients with
multiple discharges from the same hospital, using the same facility and with
the same diagnosis, are counted only once.)
• Elective admission (rate per 1000 residents)
• Non›elective admission (rate per 1000 residents)
• Mean waiting time (days)
• Ten most frequent day case diagnoses (per 1000 patients), tabulated in
descending order of frequency
• Top three day case procedures (per 1000 patients), in descending order of
frequency
Outpatient data
• Outpatient referral rate per 1000 residents
• Referral rates for five most used specialties, tabulated in descending
frequency
• Mean waiting time (days)
• Attendances at accident and emergency department (per 1000 patients)
Obstetric data
• Births (rate per 1000 registered patients)
Community data
• District nursing visits (per 1000 patients per year)
• Health visitors, visits, and clinic attendances (per 1000 patients per year)
Investigations
• Use of investigations (per 1000 patients per year) for microbiology,
haematology, biochemistry, radiology, electrocardiography
Referrals
• Physiotherapy (per 1000 patients per year, clinic and domiciliary)
• Chiropody (per 1000 patients per year, clinic and domiciliary)
• Occupational therapy (per 1000 patients per year)
Census
• Percentage of residents with limiting long term illness
• Demographic profile, in 5 year bands
• Unemployment rates (%) for men and women
• Percentage of house owners
• Percentage of car owners
• Percentage of households with lone parents
Focus groups17
• Facilitated discussion groups that allow the members of the target
population to express ideas spontaneously
• Can give useful insights into perceived needs, quality of services, and
understandings of health issue
• Can raise issues that are important to patients
• Information gained is not quantifiable
• Facilitators need some training
• A variety of groups may be necessary to be representative in some
situations
Practical points:
• Optimum size is 8›12 participants
• Facilitator introduces topics for discussion
• Proceedings are recorded using a tape recorder and later transcribed, or
notes are taken, preferably by another facilitator
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Stage 5: Collation of the information from the
different sources
At practice level
Present the major findings of each method to a meet›
ing attended by as many of the practice team as possi›
ble, and discuss what changes should be made to the
established work patterns and services the practice
offers. New initiatives identified should be prioritised
and incorporated in the practice’s business plan for the
coming year. Feedback can be given to the local hospi›
tals and community trusts if relevant.
At locality level (primary care group)
As the stages of the needs assessment may take several
months, present the major findings of each method as
they become available. Protected time is vital for prac›
tice representatives to study the information together;
starting to get a feel for the needs of the locality as the
complementary data builds up. A specific meeting,
possibly facilitated by the local public health depart›
ment, will be important to prioritise the suggestions
raised by the various sorts of data. Techniques for pri›
oritising needs include the nominal group technique,
and use of a ranking matrix can give useful structure to
such meetings. With the nominal group technique,
needs or interventions are listed, discussed, then
ranked by each participant until an agreed level of
consensus is reached. This encourages debate, and
quick decisions can be made. To use a ranking matrix,
criteria for priority interventions are defined, such as
potential to improve health, capacity to implement,
and equity implications. Participants score each poten›
tial intervention for each criterion, and the scores are
totalled.20
Health needs assessment is a cyclical process.
Needs change over time; evaluating how well needs
have been met will bring you back to assessing the
needs that have not been met by your action.
How realistic is assessment of health
needs in primary care?
Lack of planning time and the pressure to respond to
the immediate needs of patients has to date prevented
needs assessment in primary care. The fundholding
initiative, emphasising efficient purchasing of services,
has not championed needs assessment and has largely
ignored aspects of health needs not related to the
health service. The advent of locality commissioning
and the creation of primary care groups will now allow
some general practitioners protected time for needs
assessment. This strategic work is realistic and possible
and has the potential to make primary care more
effective at improving health by targeting available
resources. But resources, training, and liaison with
public health physicians will be necessary for this to
work.
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Rapid appraisal
A team, ideally with a mixture of professional insights, gathers data about
both needs and resources in the area under study from:
• Interviews with key informants (individuals with knowledge of the
community) and patients
• Available documents about the neighbourhood or community
• Observations made inside homes and in the neighbourhood
Practical points:
• Use the framework of an information pyramid18 19 to guide collection and
analysis
• Collate the needs, priorities, and solutions perecived in the community
for each box of the information pyramid
• Consider facilitating change in primary care services, commissioning of
secondary care, and local advocacy to improve wider determinants of health
Areas for questionnaire surveys
• Acute illnesses and experience of common symptoms
• Use of health services over the past 6 or 12 months
• Patients’ satisfaction
• Perceived need for current and potential services
• Specific concerns and worries that may affect health
• Specific questions for people with specific long term health problems or
carers
• Chronic illness (may not be necessary if data obtained already):
Any long term illness
Several marker conditions (for example, hypertension, back pain)
• Consider a general health status instrument (SF›36, SF›12)
• Consider a disease specific instrument
(Consider checking a sample of medical records from non›respondents.)
These articles
have been adapted
from Health Needs
Assessment in
Practice, edited by
John Wright,
which will be
published in July.
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Economics notes
Perspectives in economic evaluation
Sarah Byford, James Raftery
Before an economic evaluation begins, the perspective
of the study should be determined, as it may have
implications for trial design.1 Since economic evalua›
tions are often used to assess the relative efficiency of
alternative healthcare interventions, the perspective
commonly taken is that of the health service.2 Because
of its foundations in welfare economics, however,
health economics is concerned with society’s welfare. It
therefore argues that an economic evaluation should
include the impact of an intervention on the welfare of
the whole of society, not just on the individuals or
organisations directly involved.
Central to economic theory is the question of how
to get the most benefit from the scarce resources avail›
able to a society. An economic evaluation which
confined itself to the NHS’s perspective could
determine the mix of interventions that would maxim›
ise health outcomes within the limited NHS budget.
However, this would not necessarily maximise the wel›
fare of society within resources available (gross
national product) for two main reasons.
Firstly, sectors other than the health service may
incur costs or benefits as a result of healthcare
interventions. Consider for example, the reduction of
psychiatric hospital beds, which might seem cost effec›
tive from the perspective of the health service but less
so from that of society as a whole, including patients’ or
carers’ perspectives. A societal perspective helps detect
cost shifting between sectors.
Advantages of a societal approach
Secondly, a narrow perspective takes no account of
alternative uses for resources outside the healthcare
sector, which may yield greater welfare to society. The
concept of opportunity cost reflects this broad concern
for society’s total welfare. Because the total economic
output of society is limited, choosing to devote
resources to health care necessarily implies forgoing
the benefits (or opportunities) of using those resources
in an alternative sector, such as education or social
services, or indeed not raising them as taxes.
Since the NHS is a universally accessible service,
funded by taxation, it can be argued that its decisions
should be from the perspective of all those who use it
and pay for it—the whole population. Epidemiology
and economics share a concern with populations.
Adopting a societal or population perspective facili›
tates policies aimed at maximising the welfare gains to
society, or minimising the losses. Excluding particular
groups could hinder this process and be less equitable
than attempting to include the views of all.
The utilitarianism that underpins welfare econom›
ics has been characterised as a poor basis for a
personal philosophy (uncaring, calculating, and conse›
quentialist) but an appropriate basis for public policy.3
While a utilitarian, societal perspective can be justified
in principle, its practice can be difficult. Ethical
dilemmas can arise between individual and societal
perspectives.4 When an individual is denied (even pos›
sibly ineffective) treatment the lack of a societal
consensus can become stark. How individual prefer›
ences are to be aggregated to a societal preference
remains a theoretical and practical challenge.
To certain organisations, a societal perspective may
seem unnecessary. A clinical directorate faced with dif›
ficult decisions within a tight budget may take a direc›
torate perspective, in turn requiring the wider
organisation to act to prevent cost shifting or other
undesirable effects. For›profit organisations, such as
pharmaceutical companies, may well take a narrow
financial perspective, in turn leading to regulation by
the state to safeguard wider concerns. The emphasis in
guidelines for pharmacoeconomic evaluations to
include a societal perspective, however, is striking.
For policy purposes, study comparability is
enhanced by adopting a societal perspective as a norm.
A report for the US Public Health Service recom›
mended a societal perspective, for which it saw welfare
economics as providing the best theoretical frame›
work, for use in reference case economic evaluations—
those that aim to provide results that could be
compared throughout the healthcare system.
In practice, it may not always be possible for all the
relevant costs and benefits to be included in an
economic evaluation because of funding or time
constraints. A good case can be made for excluding
particular effects if they are likely to have little impact
on the overall results. Pretrial literature reviews and
modelling can help prioritise items of importance. A
“reduced list” method has been shown to capture most
relevant costs in mental health service evaluations,5
with the five most costly services accounting for 94% of
the total cost and the next five for only 4%. Such short
cuts require further evaluation before they are more
widely applied. A similar analysis on costing screening
for colorectal cancer found reduced list costing to be
less successful.6 As economic evaluation becomes more
standardised it may be possible to justify such limited
perspectives for costing particular diseases or services.
At the very least economic evaluations should be
explicit about the perspective they adopt. The
exclusion of items, whether for practical reasons or as a
result of pretrial assessments, must be made explicit,
explained, and discussed in terms of their likely
influence on the final results. Studies with non›societal
perspectives may result in suboptimal resource alloca›
tion decisions and a corresponding loss in the total
welfare of society.
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